

Cover Story
COVID-19 & CancerFree
By Matthew Bin Han Ong
NCI’s Frederick National Laboratory for Cancer Research has launched three initiatives focused on SARS-CoV-2.
COVID-19 Updates


In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Anthony Letai sworn in as 18th NCI director
- Bhattacharya: New grant review criterion is “not political”
- Population-based cancer surveillance is a national treasure at risk